Jacou, France

Mélodie Carluer

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Medincell S.a.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mélodie Carluer. Retrieved from https://idiyas.com/inventor/melodie-carluer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Mélodie Carluer

Introduction

Mélodie Carluer is an accomplished inventor based in Jacou, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for treating psychiatric diseases.

Latest Patents

Mélodie holds 1 patent for his work on "Olanzapine compositions and methods of use." This patent discloses pharmaceutical compositions for subcutaneous administration that include olanzapine, an organic solvent, a triblock copolymer, and a diblock copolymer. The methods outlined in this patent aim to treat various psychiatric diseases and disorders effectively.

Career Highlights

Mélodie is currently employed at Medincell S.A., where he continues to innovate in the pharmaceutical sector. His work focuses on improving drug delivery systems and enhancing the efficacy of treatments for mental health conditions.

Collaborations

Mélodie collaborates with talented professionals such as Maria Ferrand and Irina Cherniakov, contributing to a dynamic research environment that fosters innovation.

Conclusion

Mélodie Carluer's contributions to pharmaceutical innovations, particularly in psychiatric treatment, highlight his role as a key inventor in the field. His work continues to pave the way for advancements in drug delivery and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…